Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-033-5 | CAS number: 5613-46-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
No data are available that describe the toxicokinetics of Tetramethyl Bisphenol A, therefore relevant substance properties and data from toxicity studies indicating systemic bioavailability were taken together to assess the general toxicokinetics of the substance.
Physical-chemical properties
Tetramethyl Bisphenol A is a white to off-white powder with a molecular weight of 284.4 g/mol. The log Pow of the substance is 4.51. Its solubility in water is 3.17 mg/L.
Data from acute and repeated dose toxicity studies
Acute oral and dermal toxicity studies
The available acute oral and dermal toxicity studies did not result in mortality and overt signs of toxicity were not observed. In both studies the dose level was 2000 mg/kg bw.
In a combined repeated dose toxicity / reproductive toxicity screening assay, groups of 12 male and 12 female rats were exposed via gavage at doses of 0, 10, 100 and 1000 mg/kg bw/day. No parental animals died during the test. Test substance-related clinical findings of clear and red material around the mouth and/or nose were noted at approximately 1-2 hours following dose administration in the 100 and 1000 mg/kg/day groups. Test substance-related lower mean body weight gains were noted in the 100 and 1000 mg/kg/day group F0 males compared to the control group throughout the entire treatment period (study days 0-27). As a result, mean body weights in the 100 and 1000 mg/kg/day group males were 4.2% and 5.1% lower, respectively, than the control group on study day 27. Correspondingly lower mean food consumption was noted for males in these groups only during the first week of treatment (study days 0-7). During the recovery period, mean body weights, body weight gains, and food consumption in the1000 mg/kg/day group males were comparable to the control group. No test substance-related effects in the following parameters were noted in the F0 males at any dose level: FOB or locomotor activity evaluations, hematology and coagulation, serum chemistry, urinalysis, macroscopic findings at necropsy or organ weights. Test substance-related, minimal to mild vacuolation of the lamina propria in the duodenum and jejunum was noted in the 100 (duodenum only) and 1000 mg/kg/day F0 group males at the primary necropsy. These vacuoles were rarely positive with Oil red O stain and suggested lipid accumulation. Persistence of test substance-related, minimal vacuolation in the duodenum and jejunum at slightly higher incidence was noted in the 1000 mg/kg/day F0 group males at the recovery necropsy. No correlating clinical pathology alterations or effects on organ weight were noted. Therefore, the toxicological significance of vacuolation in the present study is uncertain. Similar changes were not noted in the F1 generation.
Absorption figures used for the DNEL derivation
No information on absorption of Tetramethyl Bisphenol A is available. In accordance with Chapter R.8 of REACH Guidance on information requirements and chemical safety assessment, a default factor of 2 (i.e. the absorption percentage for the starting route is half that of the end route) is proposed to be used in the case of oral-to-inhalation extrapolation. Based on the water solubility of 3.17 mg/L, the Log Pow of 4.51 and the physical state of the substance (solid), the dermal absorption will be low and the rate of penetration will be limited. Furthermore, no effects were observed in an acute dermal toxicity study. Therefore, a factor 0.1 is proposed for oral-to-dermal extrapolation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.